CIK: 1385496 - Address: 4505 Emperor Blvd., Suite 200, Durham, NC 27703
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret112-1-4-6-37-32-88-28
S%wins501005010010010083

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/2/23 17:20
2/1/23
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagStonehouse Jon PNCDOP,CEOS.d-1,03810.380-100-91,029M
12/19/22 17:09
12/15/22
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagStonehouse Jon PNCDOP,CEOS-15410.900-14-2898D
12/2/22 18:33
12/1/22
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagStonehouse Jon PNCDOP,CEOS.dm-3,85212.940-298-25912D
1/13/22 16:45
1/11/22
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagStonehouse Jon PNCDOP,CEOS.d-2,76715.040-184-17912D
12/17/20 16:20
12/15/20
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagStonehouse Jon PNCDOP,CEOS.d-1,1178.320-134-15784D
12/6/18 16:34
12/3/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagStonehouse Jon PNCDOP,CEOS.d-7309.120-80-10728D
6/22/15 16:34
6/19/15
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagStonehouse Jon PNCDOP,CEOS.d-30015.0213-20-3651D81334436455322223-3-72-16-35-83
3/5/12 17:09
3/2/12
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagStonehouse Jon PNCDOP,CEOS.d-134.782-3-1239D-30124263652212410-13-57-28-93

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact